A Little Diversification

Yesterday, I did a little reallocation of my portfolio. Since Genzyme (Ticker: GENZ) makes up a large % holding in my portfolio, I decided to diversify a bit by selling off a few shares. I sold Genzyme at $69.06, which generated a long-term gain of 73.97%. I used the proceeds from the Genzyme sale and purchased the following stocks: Goldman Sachs (Ticker: GS) @ $175.45, Genentech (Ticker: DNA) @ $83.28 and Vertex Pharmaceuticals (Ticker: VRTX) @ $36.90. I decided to take a little risk with Vertex by betting on positive clinical results and eventual FDA approval for their hepatitis C treatment.